Purchase Order 75N95C21P00111

This is a $3,893,053.00 cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit organization. The contract is for the characterization of a non-addictive small molecule therapeutic for the management of non-cancer pain, with a period of performance from September 18, 2020 to September 17, 2022, and an ultimate completion date of April 28, 2025....

This is a delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services. The contract, valued at $2,373,515.00, is for non-clinical safety evaluations of mitragynine to support its future development as an oral analgesic (pain relief) therapy. The prime contractor is the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of...

Psychogenics Inc., doing business as Psychogenics Inc., has been awarded a $45.9 million delivery order contract by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide screening of investigational agents through the Preclinical Screening Platform for Pain. The cost plus fixed fee contract will be performed over a five year period in Paramus, New Jersey. Under the contract, Psychogenics will screen investigational pain treatment agents through...

The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order valued at $22,500 to the University of Kansas Center for Research, Inc. This award is pursuant to a request for quote to develop a manufacturable tablet formulation of the compound NCGC72 for use in dog sarcoma clinical studies. The prime contractor will non-GMP manufacture 1,500 tablets total, with 1,000 tablets at 50mg dosage and 500 tablets at...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a Small Business Innovation Research (SBIR) Phase II contract to Media REZ LLC, doing business as Daniel Greenberg & Associates, for "Virtual Reality for Mobile Pain Control". The firm-fixed-price contract has a total potential value of $1,000,000.00 and a period of performance from September 15, 2017 to September 14, 2019, with a completion date of September...

This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO). The $1,340,461.88 firm fixed-price delivery order is for a clinical trial to assess the safety, tolerability, and pharmacokinetics of an investigational agent for substance use disorder (SUD) treatment. The contract is part of NIDA's $21 million indefinite delivery contract N01DA-23-8935, which supports...

This is a $42,963 federal purchase order contract awarded by the U.S. Attorney's Offices to Pain & Addiction Integrated Network, Inc., a for-profit organization. The contract provides expert witness services, medical expert reviews, and subject matter expertise related to pain management, controlled substances, and addiction treatment. This supports the government's efforts to combat prescription drug abuse and ensure proper medical practices. The contract has no set-aside designation and is...

The National Institutes of Health (NIH), an agency of the Department of Health and Human Services (HHS), awarded an $80,000 delivery order contract to the National Academy of Sciences (NAS) to conduct a workshop on non-pharmacological approaches to pain management. The contract is a cost-no-fee order against an existing NAS indefinite-delivery/indefinite-quantity contract vehicle. NAS will organize and host a one-day workshop in Washington, D.C. to explore non-drug therapies for pain...

This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The 5-year, $4,999,491.97 contract is for the synthesis and distribution of opioid and related peptides. It is a cost-plus-fixed-fee definitive contract that was awarded on February 15, 2017 and runs through February 14, 2022, with a current ultimate completion date of July 16,...

This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...